Today's Earnings Calculators Terms of Service Privacy Policy Data Sources Support Mobile app Instagram

StockRay is an AI stock analysis service by Warm Tech Company.

Warm Tech Company | CEO Jinyoung Moon | Reg. 317-27-02126

13, Cheonggyesan-ro 4-gil, Sujeong-gu, Seongnam-si, Gyeonggi-do, Korea | partner@warmtech.company

All information provided by Warm Tech Company is for reference only and does not constitute a recommendation to buy or sell any specific stock. You are solely responsible for your investment decisions.

© 2026 Warm Tech Company. All rights reserved.

GeneDx Holdings Corp. Stock Price·Forecast · AI Analysis | StockRay

GeneDx Holdings Corp.

WGS · Healthcare · $2.2B

Pre-market $72.35+0.07%

2026 Q2 earnings

Price

$67.51

$75.79

Jul 2, 26Sep 29, 26

What's this stock's score right now?

See its score for free — revenue and money flow, graded on one standard.

Quarterly Financials

RevenueOperating IncomeNet Income

9/'26

Revenue$123M+7.5%

6/'26 vs prev quarter

Company Health

Market Cap$2.2B

Operating Margin-13.3%

Free Cash Flow$-37M-1.7% of market cap

Among 39 Medical - Diagnostics & Research peers

LowMedianHigh

PSR4.7x

median 5.4x

2026 Q3 EarningsPreliminary disclosure

2026 Q2 EarningsReflected in score

2026 Q1 EarningsReflected in score

2025 Q4 EarningsPreliminary disclosure

2025 Q3 EarningsPreliminary disclosure

2025 Q2 EarningsPreliminary disclosure

Related Stocks

B
Bausch Health Companies Inc.
P
Prestige Consumer Healthcare Inc.
R
Recursion Pharmaceuticals, Inc.
C
Celldex Therapeutics, Inc.
B
BioCryst Pharmaceuticals, Inc.
M
Maravai LifeSciences Holdings, Inc.
P
Pediatrix Medical Group, Inc.
A
Aurinia Pharmaceuticals Inc.

Daily Prices

09.29$75.79-4.60%

09.28$85.93-2.79%

09.25$88.40-0.09%

09.24$88.48+3.85%

09.23$85.20-6.17%

09.22$90.80-7.19%

09.21$97.83-3.23%

09.18$101.10-3.67%

09.17$104.95+7.73%

09.16$97.42+2.94%

Quarterly Revenue Growth

PriorCurrent

25년 9월25년 12월26년 3월26년 6월26년 9월Est.

Revenue Breakdown

As of Dec 2025

Source: Company IR filings

Diagnostic Test49.4%
Diagnostic Test, Third Party Insurance40.9%
Diagnostic Test, Institutional Customers8.3%
Product and Service, Other1.3%
Diagnostic Test, Self Pay0.2%

BusinessMedical - Diagnostics & Research·genedx.com↗

“이번 분기 매출 $114M — 전 분기 $102M 저점에서 반등했고 검사 건수는 전년 대비 32% 늘어난 신기록이에요.”

In the company's words · 2026 2분기 earnings call